Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658032 · ClinicalTrials.gov registry record · NA
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)
A NA study of Smoking Cessation and Biofeedback, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
- 2
- Study locations
NCT02658032: Completed NA study of Smoking Cessation and Biofeedback, sponsored by Yale University.
NCT02658032 is a NA study of Smoking Cessation and Biofeedback that has completed, run by Yale University. The registered enrollment target is 276 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02658032, a NA study of Smoking Cessation and Biofeedback, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the efficacy of two separate, sequential interventions to promote tobacco cessation/reduction in patients who are screened for lung cancer or are eligible for lung cancer screening. Each intervention will be compared to standard of care. The first intervention will be a personalized message intervention, the second intervention will consist of a biofeedback-based intervention.
Primary Outcome
Smoking cessation will be measured by self report and validated by the study team using Carbon Monoxide (CO) levels. CO will be measured.
Conditions Studied
Interventions
- OTHER standard care
- BEHAVIORAL personalized cessation care
- BEHAVIORAL bio feedback
Study Locations (2)
Connecticut
- Yale University - New Haven
South Carolina
- Medical University of South Carolina: Hollings Cancer Center - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-10 |
| Phase | NA |
What the finished NCT02658032 record still lists
NCT02658032 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (42% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which standard care is the first listed.
NCT02658032 reports a single indexed study location in Connecticut, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02658032 about?
NCT02658032 is a clinical study titled "Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)". The purpose of this study is to test the efficacy of two separate, sequential interventions to promote tobacco cessation/reduction in patients who are screened for lung cancer or are eligible for lung cancer screening. Each intervention will be compared to standard of care. The first intervention wi...
What is the current status of trial NCT02658032?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2016-01. Estimated completion is 2020-10.
What conditions does trial NCT02658032 study?
This clinical trial studies the following conditions: Smoking Cessation, Biofeedback.
What interventions are being tested in trial NCT02658032?
The interventions under investigation include: standard care (OTHER), personalized cessation care (BEHAVIORAL), bio feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02658032?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02658032 being conducted?
This trial has 2 study locations across Connecticut, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02658032's enrollment target sits among peer trials
276 88th of 188 higher than 101 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia